Similar drugsTo uncover
Dosage form: & nbsptabscesses
Composition:

For one tablet:

Active substances: motherwort herb extract (motherwort extract dry) - 14.00 mg or 28.00 mg, ethyl bromoisovalerianate (ethyl ester of alpha-bromizovaleric acid) - 8.20 mg or 16.40 mg,mint pepper leaves oil (peppermint oil) - 0, 58 mg or 1.16 mg.

Excipients: lactose (lactose monohydrate) - 79.21 mg or 158.42 mg, betadex (beta-cyclodextrin) - 55.55 mg or 111.10 mg, potato starch - 35.56 mg or 71.12 mg, magnesium aluminometasilicate (Neusilin UFL 2) - 4.00 mg or 8.00 mg, talc-2.00 mg or 4.00 mg, magnesium stearate-0.90 mg or 1.80 mg.

Description:

Round, flat cylindrical tablets of light brown color with impregnations of lighter and darker color, with a facet and a risk, with a weak characteristic odor.

Pharmacotherapeutic group:Sedative remedy
ATX: & nbsp
  • Other sleeping pills and sedatives
  • Pharmacodynamics:

    Combined drug, the effect of which is due to the properties of its constituents. Has a sedative and spasmolytic effect, moderate cardiotonic action (slows down the rhythm and increases the strength of the heartbeat), has moderate hypotensive properties.

    Ethyl bromoisovaleric acid has a sedative and spasmolytic effect due to irritation, mainly of the oral cavity and nasopharyngeal receptors, a decrease in reflex excitability in the central parts of the nervous system and an increase in inhibition in the neurons of the cortex and subcortical structures of the brain,as well as a decrease in the activity of the central vasomotor centers and a direct local spasmolytic effect on smooth muscles. By the nature of the action is close to the drugs valerian.

    Motherwort herb has a pronounced sedative effect, reduces the frequency and increases the strength of the heartbeats, shows hypotensive properties.

    Peppermint oil has a reflex vasodilating, spasmolytic, mild choleretic, antiseptic action. The mechanism of action is associated with the ability to irritate the "cold" receptors of the oral mucosa and reflexively expand primarily the vessels of the heart and brain. Eliminates the phenomena of flatulence due to irritation of the receptors of the mucous membrane of the gastrointestinal tract (GIT), strengthening the peristalsis of the intestine.

    Pharmacokinetics:

    Data on the pharmacokinetics of ethyl bromizovalericanate, herbaceous leaves of motherwort and components of peppermint are absent.

    Indications:

    As a symptomatic (soothing and vasodilating) remedy for functional disorders of the cardiovascular system; neurosis-like conditions, accompanied by increased irritability,with a disturbance of falling asleep, tachycardia, a state of excitation with pronounced vegetative manifestations; as an antispasmodic - for intestinal spasms.

    Contraindications:

    - Hypersensitivity to the components of the drug;

    - severe impairment of kidney and / or liver function;

    - pregnancy;

    - lactation period (breastfeeding);

    - children under 18 years of age (efficacy and safety not established);

    - lactose intolerance, lactase deficiency, glucose-galactose malabsorption.

    If you have any of the listed diseases / conditions, always consult a doctor before taking the drug.

    Carefully:

    Impaired renal and / or liver function.

    Pregnancy and lactation:

    Safety of the use of the medicinal product Corvalol Phyto, tablets in pregnancy is not established, the use of the drug during pregnancy is contraindicated.

    Data on the penetration of the components of the drug into breast milk are not available, so if the need for the drug during lactation should be addressed, the issue of ending breastfeeding.

    Dosing and Administration:

    For oral administration, before meals, with water.

    For tablets, 0.58 mg + 14.00 mg + 8.20 mg: adults 2 tablets 2 times a day.

    For tablets, 1.16 mg + 28.00 mg + 16.40 mg: adults 1 tablet 2 times a day.

    With tachycardia, it is possible to increase the single dose to 3 tablets. The maximum daily dose is 6 tablets.

    The course of treatment is 4 weeks (28 days). Duration of admission can be increased on the recommendation of a doctor.

    Side effects:

    From the immune system: allergic reactions;

    From the central nervous system: drowsiness, weakness, dizziness, decreased ability to concentrate;

    From the gastrointestinal tract: indigestion.

    These phenomena occur with a decrease in the dose of the drug or discontinuation of the drug.

    With prolonged use of high doses of the drug, it is possible to develop drug dependence, as well as the accumulation of bromine in the body and the development of bromism, which manifestations are: depressive mood, apathy, rhinitis, conjunctivitis, hemorrhagic diathesis, impaired coordination of movements, drug dependence.

    If any of the side effects listed in the instruction are aggravated, or you notice any other side effects,not specified in the instructions, inform the doctor about it.

    Overdose:

    Overdose is possible with frequent and prolonged use of the drug. When the recommended dosage is exceeded, dose-dependent side effects may be increased.

    Symptoms: weakness, drowsiness, dizziness. With prolonged use, it is possible to develop chronic intoxication with bromine (see section Side effect).

    Treatment: symptomatic.

    Interaction:

    With the simultaneous use of the medicinal product Corvalol Phyto, tablets with drugs depressing the central nervous system (sedatives, hypnotics, antipsychotics, tranquilizers), there may be a mutual enhancement of the effects.

    Strengthens the effect of antispasmodic, analgesic agents.

    Alcohol enhances the effect of the drug and its toxicity.

    Special instructions:

    The experience of using the drug in children under 18 years of age, during pregnancy and during breastfeeding is absent.

    It is not recommended long-term use of the drug in high doses, in connection with possible toxic effects during the cumulation of bromine in the body.

    During the use of the drug should not drink alcohol.

    Effect on the ability to drive transp. cf. and fur:

    In connection with the possibility of dizziness, reduced concentration and other side effects associated with taking the drug, during treatment, patients are advised to refrain from managing motor vehicles and taking other potentially dangerous activities that require increased concentration of attention, speed of psychomotor and motor reactions.

    Form release / dosage:Tablets, 0.58 mg + 14.00 mg + 8.20 mg and 1.16 mg + 28.00 mg + 16.40 mg.
    Packaging:

    For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

    1, 2, 3, 4 or 5 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.
    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:PL-003969
    Date of registration:18.11.2016
    Expiration Date:18.11.2021
    The owner of the registration certificate:PHARMSTANDART-FORESTRY, OJSC PHARMSTANDART-FORESTRY, OJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp18.01.2018
    Illustrated instructions
      Instructions
      Up